Prof. Dr. Astrid Weyerbrock
Multifocal lumbar disc herniation at a single level: a potential pitfall for wrong side surgery.
Fiechter M, Weyerbrock A, Fournier J. Multifocal lumbar disc herniation at a single level: a potential pitfall for wrong side surgery. Br J Neurosurg 2018; 35:120-121.
10.08.2018Multifocal lumbar disc herniation at a single level: a potential pitfall for wrong side surgery.
10.08.2018Br J Neurosurg 2018; 35:120-121
Fiechter Michael, Weyerbrock Astrid, Fournier Jean-Yves
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial
Weyerbrock A. Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol 2018; 2018 Aug
08.08.2018Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial
08.08.2018J Cancer Res Clin Oncol 2018; 2018 Aug
Weyerbrock Astrid
Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study.
Stienen M, Scholtes F, Samuel R, Weil A, Weyerbrock A, Surbeck W. Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study. BMJ Open 2018; 8:e021310.
07.07.2018Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study.
07.07.2018BMJ Open 2018; 8:e021310
Stienen Martin N, Scholtes Felix, Samuel Robin, Weil Alexander, Weyerbrock Astrid, Surbeck Werner
Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study
Weyerbrock A. Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study. BMJ Open 2018; 2018 Jul
01.07.2018Different but similar: personality traits of surgeons and internists-results of a cross-sectional observational study
01.07.2018BMJ Open 2018; 2018 Jul
Weyerbrock Astrid
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Schäfer N, Proescholdt M, Steinbach J, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch M, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol 2018; 20:975-985.
18.06.2018Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
18.06.2018Neuro Oncol 2018; 20:975-985
Schäfer Niklas, Proescholdt Martin, Steinbach Joachim P, Weyerbrock Astrid, Hau Peter, Grauer Oliver, Goldbrunner Roland, Friedrich Franziska, Rohde Veit, Ringel Florian, Schlegel Uwe, Sabel Michael, Ronellenfitsch Michael W, Uhl Martin, Grau Stefan, Hänel Mathias, Schnell Oliver, Krex Dietmar, Vajkoczy Peter, Tabatabai Ghazaleh, Mack Frederic, Schaub Christina, Tzaridis Theophilos, Nießen Michael, Kebir Sied, Leutgeb Barbara, Urbach Horst, Belka Claus, Stummer Walter, Glas Martin, Herrlinger Ulrich
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Weyerbrock A. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol 2018; 2018 Jun
01.06.2018Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
01.06.2018Neuro Oncol 2018; 2018 Jun
Weyerbrock Astrid
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Schaub C, Kebir S, Junold N, Hattingen E, Schäfer N, Steinbach J, Weyerbrock A, Hau P, Goldbrunner R, Nießen M, Mack F, Stuplich M, Tzaridis T, Bähr O, Kortmann R, Schlegel U, Schmidt-Graf F, Rohde V, Braun C, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Herrlinger U, Glas M. Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol 2018; 144:1581-1589.
28.05.2018Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
28.05.2018J Cancer Res Clin Oncol 2018; 144:1581-1589
Schaub Christina, Kebir Sied, Junold Nina, Hattingen Elke, Schäfer Niklas, Steinbach Joachim P, Weyerbrock Astrid, Hau Peter, Goldbrunner Roland, Nießen Michael, Mack Frederic, Stuplich Moritz, Tzaridis Theophilos, Bähr Oliver, Kortmann Rolf-Dieter, Schlegel Uwe, Schmidt-Graf Friederike, Rohde Veit, Braun Christian, Hänel Mathias, Sabel Michael, Gerlach Rüdiger, Krex Dietmar, Belka Claus, Vatter Hartmut, Proescholdt Martin, Herrlinger Ulrich, Glas Martin
Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage
Weyerbrock A. Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage. J Neurosurg 2018; Nov;127(5)::1070--1076.
10.03.2018Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage
10.03.2018J Neurosurg 2018; Nov;127(5)::1070--1076
Weyerbrock Astrid
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Beier D, Proescholdt M, Reinert C, Pietsch T, Jones D, Pfister S, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J, Warmuth-Metz M, Bonsanto M, Bremer M, Combs S, Rieken S, Herrlinger U, Kuntze H, Mayer-Steinacker R, Moskopp D, Schneider T, Beringer A, Schlegel U, Stummer W, Welker H, Weyerbrock A, Paulsen F, Rutkowski S, Weller M, Wick W, Kortmann R, Bogdahn U, Hau P. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol 2018; 20:400-410.
19.02.2018Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
19.02.2018Neuro Oncol 2018; 20:400-410
Beier Dagmar, Proescholdt Martin, Reinert Christiane, Pietsch Torsten, Jones David T W, Pfister Stefan M, Hattingen Elke, Seidel Clemens, Dirven Linda, Luerding Ralf, Reijneveld Jaap, Warmuth-Metz Monika, Bonsanto Matteo, Bremer Michael, Combs Stephanie E, Rieken Stefan, Herrlinger Ulrich, Kuntze Holger, Mayer-Steinacker Regine, Moskopp Dag, Schneider Thomas, Beringer Andreas, Schlegel Uwe, Stummer Walter, Welker Helmut, Weyerbrock Astrid, Paulsen Frank, Rutkowski Stefan, Weller Michael, Wick Wolfgang, Kortmann Rolf-Dieter, Bogdahn Ulrich, Hau Peter
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
Weyerbrock A. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol 2018; 2018 Feb
08.02.2018Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
08.02.2018Neuro Oncol 2018; 2018 Feb
Weyerbrock Astrid
Surgical Treatment of Mesiotemporal Lobe Epilepsy: Which Approach is Favorable?
Schmeiser B, Weyerbrock A, Scheiwe C, Prinz M, Steinhoff B, Wendling A, Mader I, Schulze-Bonhage A, Wagner K, Zentner J. Surgical Treatment of Mesiotemporal Lobe Epilepsy: Which Approach is Favorable?. Neurosurgery 2017; 81:992-1004.
01.12.2017Surgical Treatment of Mesiotemporal Lobe Epilepsy: Which Approach is Favorable?
01.12.2017Neurosurgery 2017; 81:992-1004
Schmeiser Barbara, Weyerbrock Astrid, Scheiwe Christian, Prinz Marco, Steinhoff Bernhard Jochen, Wendling Anne-Sophie, Mader Irina, Schulze-Bonhage Andreas, Wagner Kathrin, Zentner Josef
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation
Heckler M, Osterberg N, Guenzle J, Thiede-Stan N, Reichardt W, Weidensteiner C, Saavedra J, Weyerbrock A. The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation. Tumour Biol 2017; 39:1010428317703922.
01.06.2017The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation
01.06.2017Tumour Biol 2017; 39:1010428317703922
Heckler Max, Osterberg Nadja, Guenzle Jessica, Thiede-Stan Nina Kristin, Reichardt Wilfried, Weidensteiner Claudia, Saavedra Joseph E, Weyerbrock Astrid
Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression
Fedele V, Bredel M, Iavarone A, Califano A, Prinz M, Weyerbrock A, Nelander S, Kim H, Doostkam S, Platania L, Ferrarese R, Gätjens-Sanchez A, Kling E, Heiland D, Masilamani A, Dai F, Carro M. Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression. Mol Cancer Res 2017; 15:998-1011.
16.05.2017Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression
16.05.2017Mol Cancer Res 2017; 15:998-1011
Fedele Vita, Bredel Markus, Iavarone Antonio, Califano Andrea, Prinz Marco, Weyerbrock Astrid, Nelander Sven, Kim Hyunsoo, Doostkam Soroush, Platania Leonardo, Ferrarese Roberto, Gätjens-Sanchez Ana M, Kling Eva, Heiland Dieter H, Masilamani Anie P, Dai Fangping, Carro Maria S
Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme
Heiland D, Weyerbrock A, Urbach H, Staszewski O, Kiselev V, Kellner E, Pfeifer D, Haaker G, Demerath T, Simon-Gabriel C, Mader I. Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme. Sci Rep 2017; 7:43523.
07.03.2017Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme
07.03.2017Sci Rep 2017; 7:43523
Heiland Dieter Henrik, Weyerbrock Astrid, Urbach Horst, Staszewski Ori, Kiselev Valerij G, Kellner Elias, Pfeifer Dietmar, Haaker Gerrit, Demerath Theo, Simon-Gabriel Carl Philipp, Mader Irina
ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFB and STAT3 inhibition in glioblastoma
Guenzle J, Wolf L, Garrelfs N, Goeldner J, Osterberg N, Schindler C, Saavedra J, Weyerbrock A. ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFB and STAT3 inhibition in glioblastoma. Cell Death Discov 2017; 3:17006.
27.02.2017ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFB and STAT3 inhibition in glioblastoma
27.02.2017Cell Death Discov 2017; 3:17006
Guenzle Jessica, Wolf Louisa J, Garrelfs Nicklas W C, Goeldner Jonathan M, Osterberg Nadja, Schindler Cora R, Saavedra Joseph E, Weyerbrock Astrid
Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme
Weyerbrock A. Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme. Oncotarget 2017; 8(7)::11083--11093.
14.02.2017Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme
14.02.2017Oncotarget 2017; 8(7)::11083--11093
Weyerbrock Astrid
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex
Weyerbrock A. Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex. Cereb Cortex 2017; Feb 1; 27(2):1558-1572.
10.02.2017Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex
10.02.2017Cereb Cortex 2017; Feb 1; 27(2):1558-1572
Weyerbrock Astrid
Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
Heiland D, Prinz M, Weyerbrock A, Carro M, Pfeifer D, Gäbelein A, Heynckes S, Masalha W, Mercas B, Delev D, Haaker G, Schnell O. Comprehensive analysis of PD-L1 expression in glioblastoma multiforme. Oncotarget 2017
02.02.2017Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
02.02.2017Oncotarget 2017
Heiland Dieter Henrik, Prinz Marco, Weyerbrock Astrid, Carro Maria Stella, Pfeifer Dietmar, Gäbelein Annette, Heynckes Sabrina, Masalha Waseem, Mercas Bianca, Delev Daniel, Haaker Gerrit, Schnell Oliver
c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas
Heiland D, Nelander S, Kling T, Weyerbrock A, Kling E, Masilamani A, Dai F, Claus R, Ferrarese R, Carro M. c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas. Oncotarget 2017; 8:6940-6954.
24.01.2017c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas
24.01.2017Oncotarget 2017; 8:6940-6954
Heiland Dieter H, Nelander Sven, Kling Teresia, Weyerbrock Astrid, Kling Eva, Masilamani Anie P, Dai Fangping, Claus Rainer, Ferrarese Roberto, Carro Maria S
Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage
Jabbarli R, Reinhard M, Roelz R, Kaier K, Weyerbrock A, Taschner C, Scheiwe C, Shah M. Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage. J Neurosurg 2016:1-7.
23.12.2016Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage
23.12.2016J Neurosurg 2016:1-7
Jabbarli Ramazan, Reinhard Matthias, Roelz Roland, Kaier Klaus, Weyerbrock Astrid, Taschner Christian, Scheiwe Christian, Shah Mukesch